Professional Webinars

The Spectrum of MDS: Disease Management and Patient Education

The symposium was presented through the ONS Bridge platform on Thursday April, 29th targeted to clinical nursing professionals in oncology. Case studies were used to illustrate treatment decision-making and therapeutic challenges.

Educational Objectives

After completing this activity, the participant should be better able to:

• Explain the methods used to diagnose, stratify and treat MDS
• Identify current and emerging treatment options for patients with low-risk MDS, high-risk MDS, and secondary AML
• Analyze the nurse's role in managing treatment for MDS based on clinical presentations, diagnostic workups, transfusion dependence, comorbidities, and clinical trial consideration
• Discuss strategies to address treatment goals and decision-making, educate patients and provide palliative care to improve outcomes

Target Audience

This activity is intended for nurses and nurse practitioners engaged in the care of patients withMyelodysplastic Syndromes(MDS).

Integrating Innovative Treatments into a Cohesive Patient Care Model

This CE activity has been developed in collaboration with the Aplastic Anemia and MDS International Foundation, and was presented at the Friday Satellite Symposium preceding the 62nd ASH Annual Meeting and Exposition on December 4, 2020.

This Satellite Symposium, which preceded the 61st ASH Annual meeting, was organized by the Cleveland Clinic Taussig Cancer Institute Leukemia Program and the Aplastic Anemia and MDS International Foundation.

The complementary enduring program provides an in-depth and up-to-date review of research related to the biology, prognosis, natural history, and therapeutic management of patients with myeloid malignancies including aplastic anemia, paroxysmal nocturnal hemoglobinuria, MDS, AML, MPN and related myeloid malignancies. This program brought together leaders in disease research and clinical practice to explore solutions to improving the care of these patient populations.

The symposium, recorded for the virtual ONS Bridge platform on September, 17th 2020, is targeted to clinical nursing professionals in oncology. Case studies will be used to illustrate treatment decision-making and therapeutic challenges.

Topics include:

• Latest developments in diagnosing and treating myeloid malignancies;
• Emerging treatment options for low-risk MDS, high-risk MDS, AML, and MDS/MPN overlap;
• Disease management for chronic anemia, side effects and treatment adherence;
• Psychosocial considerations and palliative care to improve the quality of life for this patient population.

Presenters:

• Christina Cline, RN, BSN, CCRC, Senior Registered Nurse Manager,
  
  University of Florida, Gainesville, FL
• Allyson Price, MPAS, PA-C, Physician Assistant, Department of Leukemia,
  
  University of Texas MD Anderson Cancer Center, Houston, TX
• Kirsten Roblee, RN, BSN, OCN, Assistant Nurse Manager,
  
  The James Cancer Hospital and Solove Research Institute, Columbus, OH

Method of Participation

There are no fees for participating in and receiving credit for this activity. Participants must:

1. Read the learning outcomes and faculty disclosures
2. Watch and study the educational activity
3. Successfully complete the Nursing CE Assessment with a score of 70% or better
4. Complete the evaluation form

Once you’ve completed the appropriate steps and scored a 70% or greater, you will be able to download/print your certificate

Estimated time to complete activity: 1.5 hours

Date of initial release: November 9, 2020

Valid for CE credit through: November 8, 2021

• Friday, December 6, 2019 | 12:00-4:00 pm
• Orange County Convention Center
• Orlando, FL

This Satellite Symposium, which preceded the 61st ASH Annual meeting, was organized by the Cleveland Clinic Taussig Cancer Institute Leukemia Program and the Aplastic Anemia and MDS International Foundation.

The complimentary enduring program provides an in-depth and up-to-date review of research related to the biology, prognosis, natural history, and therapeutic management of patients with aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH), myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML). The program brought together leaders in disease research and clinical practice to explore solutions on improving the care of patients.